{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.62","value":"0.5"},{"groupId":"OG001","spread":"1.32","value":"1.4"}]}],"title":"Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.08","value":"1.2"},{"groupId":"OG001","spread":"1.46","value":"1.9"}]}],"title":"Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.24","value":"1.8"},{"groupId":"OG001","spread":"1.71","value":"2.7"}]}],"title":"Grade 2"}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"description":"The duration in days of mild, moderate and severe neutropenia will be recorded for 4 chemotherapy cycles. Grade 2 neutropenia is when a patient's ANC\\<1.5x10\\^9/L, Grade 3 neutropenia is when a patient's ANC\\<1.0x10\\^9/L, and Grade 4 neutropenia is when a patient's ANC \\<0.5x10\\^9/L.","dispersionType":"Standard Deviation","groups":[{"description":"F-627, 20 mg fixed dose pre-filled syringe, dosed Day 2 of each of 4 chemotherapy cycles.","id":"OG000","title":"F-627"},{"description":"Placebo, pre-filled syringe administered Day 2 of the first chemotherapy cycle; and F-627, 20 mg fixed dose pre-filled syringe administered Day 2 of each of the following 3 chemotherapy cycles.","id":"OG001","title":"Placebo"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"4 chemotherapy cycles, about 12 weeks","title":"The Duration in Days of Grade 2 (Mild), Grade 3 (Moderate) and 4 (Severe) Neutropenia Over All Cycles.","type":"SECONDARY","unitOfMeasure":"days"}